Author:
Coarelli Giulia,Heinzmann Anna,Ewenczyk Claire,Fischer Clara,Chupin Marie,Monin Marie-Lorraine,Hurmic Hortense,Calvas Fabienne,Calvas Patrick,Goizet Cyril,Thobois Stéphane,Anheim Mathieu,Nguyen Karine,Devos David,Verny Christophe,Ricigliano Vito A G,Mangin Jean-François,Brice Alexis,Tezenas du Montcel Sophie,Durr Alexandra
Funder
Assistance Publique - Hôpitaux de Paris
Reference26 articles.
1. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond;Durr;Lancet Neurol,2010
2. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study;Jacobi;Lancet Neurol,2015
3. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2;Scoles;Nature,2017
4. Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models;Moore;Mol Ther Nucl Acid,2017
5. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial;Ristori;Neurology,2010
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献